Fellows' Journal Club

2020-2021 Academic Year

Date Speaker Title Download
Apr 7, 2021 Alice Zhou Gastrointestinal Cancer
Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
➤ PubMed
Bindiya Patel Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer ➤ PubMed
Apr 21, 2021 Miriam Jacobs Genitourinary Cancers
Lenvatinib Plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
➤ PubMed
Dhruv Bansal Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma ➤ PubMed
Apr 29, 2021 Vanessa Eulo Breast Cancer
Efficacy of Margetuximab Vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial
➤ PubMed
Gradon Nielsen Pembrolizumab for Early Triple-Negative Breast Cancer ➤ PubMed
May 6, 2021 David Russler-Germain Melanoma
Five-Year Analysis of Adjuvant Dabrafenib Plus Trametinib in Stage III Melanoma
➤ PubMed
Michael Kramer Fecal Microbiota Transplant Promotes Response in Immunotherapy-Refractory Melanoma Patients ➤ PubMed
May 13, 2021 Raya Saba Benign Hematology / Myeloma
Long-Term Outcomes With Emicizumab Prophylaxis for Hemophilia A With or Without FVIII Inhibitors From the HAVEN 1-4 Studies
➤ PubMed
Zach Crees Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma ➤ PubMed
May 25, 2021 Michael Slade Thrombosis / Bleeding Disorders
Apixaban for the Treatment of Venous Thromboembolism Associated With Cancer
➤ PubMed
Fahrettin Covut Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial ➤ PubMed
Jun 2, 2021 Lauren Shea Lymphoma
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412
➤ PubMed
Mary-Kate Malecek Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma ➤ PubMed
- - ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma ➤ PubMed
Jun 9, 2021 Ryan Day Myeloma / Leukemia
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
➤ PubMed
Scott Goldsmith Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma (DREAMM-2): A Two-Arm, Randomised, Open-Label, Phase 2 Study ➤ PubMed
Jun 16, 2021 Andrew Young Gyn Onc Malignancies
A Single-Cell Landscape of High-Grade Serous Ovarian Cancer
➤ PubMed
Michael Iglesia Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer ➤ PubMed
Jun 24, 2021 Whitney Hensing Lung Cancer
First-Line Nivolumab Plus Ipilimumab Combined With Two Cycles of Chemotherapy in Patients With Non-Small-Cell Lung Cancer (CheckMate 9LA): An International, Randomised, Open-Label, Phase 3 Trial
➤ PubMed
- - First-Line Nivolumab + Ipilimumab + Two Cycles of Chemotherapy Versus Chemotherapy Alone (4 Cycles) in Patients With Advanced Non-Small-Cell Lung Cancer: 2-Year Update From CheckMate 9LA ➤ .pptx